Pictet Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$395K Hold
8,358
﹤0.01% 1649
2026
Q1
$495K Sell
8,358
-28
-0.3% -$1.82K ﹤0.01% 1464
2025
Q4
$517K Buy
8,386
+842
+11% +$51.5K ﹤0.01% 1425
2025
Q3
$471K Hold
7,544
﹤0.01% 1410
2025
Q2
$602K Sell
7,544
-137
-2% -$11.5K ﹤0.01% 1272
2025
Q1
$660K Buy
7,681
+462
+6% +$37.9K ﹤0.01% 1231
2024
Q4
$564K Buy
7,219
+1,102
+18% +$85.6K ﹤0.01% 1312
2024
Q3
$441K Hold
6,117
﹤0.01% 1384
2024
Q2
$421K Buy
6,117
+734
+14% +$49.7K ﹤0.01% 1354
2024
Q1
$391K Buy
5,383
+173
+3% +$11.6K ﹤0.01% 1417
2023
Q4
$319K Hold
5,210
﹤0.01% 1506
2023
Q3
$298K Buy
+5,210
New +$315K ﹤0.01% 1480

Other funds holding PBH

Pictet Asset Management's PBH Position: Q2 2026 in Review

Pictet Asset Management held its Prestige Consumer Healthcare (PBH) position steady in Q2 2026 at 8,358 shares worth $395K. The position accounts for ﹤0.01% of the portfolio, ranked #1649.

Pictet Asset Management first reported a position in PBH in Q3 2023 and has held it in 12 quarters since. The position peaked at $660K in Q1 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Pictet Asset Management held 8,358 shares of Prestige Consumer Healthcare worth $395K as of Q2 2026.
  • Pictet Asset Management left its Prestige Consumer Healthcare share count unchanged in Q2 2026.
  • Prestige Consumer Healthcare made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1649 holding.
  • Pictet Asset Management first reported a position in Prestige Consumer Healthcare in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Prestige Consumer Healthcare position peaked at $660K in Q1 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.